Condition: Bladder Cancer · Urinary Bladder Neoplasms · Sponsor: Merck Sharp & Dohme LLC
Researchers are looking for new ways to treat high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder and has not spread to the bladder muscle or outside of the bladder. In standard treatment for HR NMIBC, doctors first remove the tumor with a procedure called transurethral resection of the bladder tumor (TURBT). Researchers want to learn if using MK-3120, the study medicine, can treat HR NMIBC after TURBT. The goal of this study is to learn about the safety of MK-3120 and if people tolerate it.
This description comes directly from the study's public registry record.
Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
Always discuss trial participation with your own doctor first.
| Michael G Oefelein Clinical Trials ( Site 0005) | Bakersfield, California, United States | Recruiting |
| Carolina Urologic Research Center ( Site 0006) | Myrtle Beach, South Carolina, United States | Recruiting |
| Medizinische Universität Wien ( Site 0021) | Vienna, State of Vienna, Austria | Recruiting |
| UZ Gent ( Site 0031) | Ghent, Oost-Vlaanderen, Belgium | Recruiting |
| CHU de Quebec - Hopital de l'Enfant-Jesus ( Site 0011) | Québec, Quebec, Canada | Recruiting |
| Gustave Roussy ( Site 0041) | Villejuif, Val-de-Marne, France | Recruiting |
| European Interbalkan Medical Center ( Site 0051) | Thessaloniki, Greece | Recruiting |
| Rabin Medical Center ( Site 0062) | Petah Tikva, Israel | Recruiting |
| Centro Ricerche Cliniche di Verona ( Site 0072) | Verona, Veneto, Italy | Recruiting |
| Nederlands Kanker Instituut Antoni van Leeuwenhoek (NKI AVL) ( Site 0081) | Amsterdam, North Holland, Netherlands | Recruiting |
| Akershus Universitetssykehus ( Site 0091) | Lorenskog, Akershus, Norway | Recruiting |
| Hospital Universitario Virgen de la Victoria ( Site 0111) | Málaga, Andalusia, Spain | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07222488